| 10.64 0.29 (2.8%) | 07-31 16:00 | |||||||||||||
|
|
| Short term | ||||
| Mid term | ||||
| Targets | 6-month : | 13.22 | 1-year : | 14.33 |
| Resists | First : | 11.32 | Second : | 12.27 |
| Pivot price | 11.19 |
|||
| Supports | First : | 9.79 | Second : | 8.14 |
| MAs | MA(5) : | 10.55 |
MA(20) : | 11.16 |
| MA(100) : | 13.91 |
MA(250) : | 14.58 |
|
| MACD | MACD : | -0.4 |
Signal : | -0.4 |
| %K %D | K(14,3) : | 19.8 |
D(3) : | 14.5 |
| RSI | RSI(14): 41.4 |
|||
| 52-week | High : | 20.33 | Low : | 9.7 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ CLB ] has closed above bottom band by 24.7%. Bollinger Bands are 9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 10.92 - 10.97 | 10.97 - 11.02 |
| Low: | 10.1 - 10.15 | 10.15 - 10.21 |
| Close: | 10.54 - 10.64 | 10.64 - 10.73 |
Core Laboratories N.V. (CLB) is a global provider to the oil and gas sector, delivering specialized services and products for characterizing subterranean reservoirs and optimizing hydrocarbon extraction. The company's operations are distinctly segmented into Reservoir Description and Production Enhancement. The Reservoir Description division meticulously analyzes petroleum reservoir rock, fluid, and gas samples. This detailed scientific examination aims to boost the yield and enhance the recovery of oil and gas from clients' reservoirs. Offerings in this segment encompass comprehensive laboratory analysis and on-site field evaluations to determine the properties of crude oil and refined products, alongside performing proprietary and collaborative industry research studies. Conversely, the Production Enhancement segment furnishes an array of services and products vital for well completions, perforations, stimulation processes, and general production activities. This includes providing integrated diagnostic tools designed to assess the efficacy of well completions and to devise strategies for more effective enhanced oil recovery initiatives. Core Laboratories markets and sells its solutions through diverse channels, including direct sales representatives, educational seminars, industry trade exhibitions, print advertising, and a network of distributors. Established in 1936, the company boasts a significant international presence, conducting operations in approximately 50 countries, with its corporate headquarters situated in Amstelveen, the Netherlands.
Fri, 31 Jul 2026
Core Laboratories Inc. (NYSE:CLB) Sees Large Decline in Short Interest - MarketBeat
Fri, 31 Jul 2026
Q2 2026 Core Laboratories Inc Earnings Call Transcript - GuruFocus
Fri, 31 Jul 2026
Core Laboratories Q2 Earnings Call Highlights - TradingView
Thu, 30 Jul 2026
Earnings call transcript: Core Laboratories misses Q2 2026 EPS forecast - Investing.com
Thu, 30 Jul 2026
Core Laboratories N.V. Q2 2026 Earnings Call Summary - Yahoo Finance
Thu, 30 Jul 2026
Core Laboratories Inc. (NYSE:CLB) Declares $0.01 Quarterly Dividend - MarketBeat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NYSE
|
|
|
Sector:
Energy
|
|
|
Industry:
Oil & Gas Equipment & Services
|
|
| Shares Out | 46 (M) |
| Shares Float | 45 (M) |
| Held by Insiders | 1.4 (%) |
| Held by Institutions | 113.8 (%) |
| Shares Short | 4,020 (K) |
| Shares Short P.Month | 5,540 (K) |
| EPS | 0.61 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 5.84 |
| Profit Margin | 5.5 % |
| Operating Margin | 1.6 % |
| Return on Assets (ttm) | 4.8 % |
| Return on Equity (ttm) | 11 % |
| Qtrly Rev. Growth | -1.4 % |
| Gross Profit (p.s.) | 2.26 |
| Sales Per Share | 11.38 |
| EBITDA (p.s.) | 1.31 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 34 (M) |
| Levered Free Cash Flow | 44 (M) |
| PE Ratio | 17.44 |
| PEG Ratio | 1.4 |
| Price to Book value | 1.82 |
| Price to Sales | 0.93 |
| Price to Cash Flow | 14.28 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |